


| Key | % Net Assets |
|---|---|
| 7.0% | |
| 5.6% | |
| 5.2% | |
| 4.9% | |
| 77.3% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 7.0% |
| BP | 5.6% |
| BG | 5.2% |
| BAE Systems | 4.9% |
| BG | 4.5% |
| Rentokil Initial | 4.4% |
| AstraZeneca | 4.3% |
| Imperial Tobacco | 4.1% |
| Legal & General | 3.9% |
| Roche | 3.4% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 598.67p |
| Currency | GBP |
| Change | -0.34p |
| % | -0.06% |
| YTD change | 71.79p |
| YTD % | 13.63% |
| Fund Inception | 12/06/1987 |
|---|---|
| Fund Manager | Ed Burke |
| TER | 1.69 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | £100 |
| Savings | £20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.66% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.10 |
You are here: research